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The End of NAFTA and 
a Future for Companies 
in the Medical Device 
Industry
MELISSA GUIMOND and JENNIFER KROUSE, 
with KYLE BEAUREGARD
In 1994, the North American Free Trade Agreement (NAFTA) created one of the world’s largest free trade zones and established the foundation for economic growth and increased prosperity for 
Canada, the United States, and Mexico. This essay sets 
out to examine how proposed changes to NAFTA could 
affect the Medical Device Industry.1  In recent weeks, 
U.S. President Donald Trump has threatened to scrap 
NAFTA or limit the number of economic sectors that 
“free trade” with Canada and Mexico could encompass. 
Were this to happen, the medical device industry 
could be impacted in both positive and negative ways. 
These possible changes create positive impacts for both 
Canada and Mexico. Most of the possibly negative 
changes directly impact the United States. Our research 
analyzes external environmental factors and the industry 
as a whole. We look at how the proposed changes 
could affect three major companies operating in the 
NAFTA region: GE Healthcare, Johnson & Johnson, 
and Medtronic. Through our research, we are able to 
generate potential strategies for each of these companies 
should the possible changes to NAFTA occur. 
While studying the impact of the potential 
changes of NAFTA in regard to the Medical Device 
Industry, we first need to learn about how the industry 
is currently doing and how potential changes proposed 
could affect the industry. Our research of the Medical 
Device Industry uses a strategic audit approach to 
analyze and make recommendations to the top three 
companies in the NAFTA region. Were NAFTA to 
be scrapped or severely limited, there are a number of 
likely impacts on the Medical Device Industry in the 
United States. First, Mexico and Canada could retaliate 
by imposing restrictions on United States products 
that currently have favorable trade terms and high sales 
volume. Second, there is the potential for a lower trade 
deficit between Mexico and Canada. Third, scrapping 
NAFTA might bring about an end to the Value-added 
Tax (VAT). The VAT is a type of general consumption 
tax that is added incrementally throughout each stage 
of production or distribution. This would increase 
profit margins for many companies, including those in 
medical device production. Lastly, there could be more 
complications involved when American-owned factories 
stationed in Mexico are moved back to the United States 
(Varney, 2017).  
Context
Our research includes an assessment of the industry as a 
whole within the NAFTA countries, its top sectors, top 
trends, and the current performance of GE Healthcare, 
Johnson & Johnson and Medtronic. We also use 
Porter’s Five Forces, a tool to analyze the competition 
of businesses, to assess the Medical Device Industry. It 
 1 Editors’ note. This essay was written in early Spring 2018, months 
before the October 2018 conclusion of negotiations resulting in 
the United States-Mexico-Canada Trade Agreement (USMCA), the 
successor to the North American Free Trade Agreement (NAFTA). 
This scholarship provides scholarly insight into the subject that was 
available at that moment.
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Figure 1: Basic Facts about Healthcare in NAFTA’s Three Countries
Canada Mexico United States
Population 35,099,836 121,736,809 321,368,864
Total Healthcare 
Spending
$186 Billion $82 Billion $3 Trillion
Healthcare expenditures 
total (% of GDP)
10.4% 6.3% 17.1%
Healthcare expenditures 
per capita
$5,292 USD $677 USD $9,403 USD
Expenditures on 
healthcare
Gov’t 71%, 
Private 29%
Gov’t 52%, Private 48% Gov’t 48%, 
Private 52%
Size of medical device 
market
$6.2 Billion 
USD
$5 Billion USD $147.7 Billion 
USD
is a five-force model that determines the competitive 
intensity or attractiveness of a company in regard to 
its profitability. Figure 1 details some basic facts about 
the medical device industry within Canada, Mexico 
and the United States. The US dollar is very strong 
and constitutes one of the reasons why the medical 
device market is on the rise. However, the strong dollar 
creates challenges for American device manufacturers 
exporting to markets with weaker currencies (Corpart, 
2018). Comparing the NAFTA countries gives a deeper 
understanding of how each country values healthcare 
and the medical device industry.       
The Frost & Sullivan website provides a complete 
2017 snapshot of the Medical Device Industry. 
According to it, the top five sectors of 2017 were: 
structural heart, robotics and robot assistance, neuro-
devices, integrated patient monitoring devices, and 
diabetes care. Some of the top technology trends relate 
directly to the top sectors, such as the revolution of 
diabetes care, surgical robots, and devices that connect 
cars and trucks with health sensors. Health sensors 
placed on the steering wheels of cars can detect heart 
attacks, seizures and other health conditions that could 
happen while driving (though this device is still in the 
early development stage). With innovation in medical 
devices, though, there are always some unexpected issues 
that occur. In 2017, some of the concerns raised by 
innovation in the medical device industry included those 
concerning a restrictive regulatory environment, the 
speed of technology, the ability to raise capital to fund 
innovations and the changes in customer behavior and 
demands. The medical industry is constantly changing 
and it is extremely difficult to make sure that products 
and devices are reliable.  In 2017, there was also a 
transformation in the medical device industry ecosystem. 
Companies in this sector developed a connected 
60 • The Undergraduate Review • Special Issue • 2018 BRIDGEWATER STATE UNIVERSITY
ecosystem of sensors and devices that are readily available 
to individuals and that serve the functions of identifying, 
capturing and measuring health data, stratifying risks, 
informing patients of conditions, and helping them and 
their physicians to make decisions and take action. These 
sensors and devices can be placed on an individual’s 
body, in their homes, in community centers, in clinics 
and, of course, in hospitals (Frost & Sullivan, 2017). 
These sensors are extremely important for innovation 
for consumers, such as those with diabetes, who use 
them multiple times a day to check blood sugar levels. 
The medical device industry is constantly changing 
and evolving with new technologies. These changes can 
be seen in the current performances of the companies 
Medtronic, Johnson & Johnson, and GE Healthcare.
Medtronic
Medtronic is a Global Healthcare and Medical 
Device company located in Mansfield, Massachusetts. 
Medtronic’s mission statement claims that its first 
priority is “to contribute to human welfare by 
application of biomedical engineering in the research, 
design, manufacture, and sale of instruments or 
appliances that alleviate pain, restore health, and extend 
life” (Medtronic). Medtronic is growing innovation in 
the area of biomedical engineering. In 2017, it invested 
more than $2 Billion in research and development, 
which represented 7.4% of the company’s net sales that 
year. Medtronic also launched labs to bring about new 
initiatives to deliver financially sustainable businesses 
that expand access and reduce health inequality in 
emerging countries (Vivanco, 2017). Medtronic was 
a very charitable company in 2017. It donated more 
than $101 million to charitable causes in corporate cash 
contributions given through the Medtronic Foundation, 
in product donations and through employee 
volunteering. The four main product and service 
focuses of Medtronic are cardiac and vascular afflictions, 
restorative therapies, diabetes, and minimally invasive 
therapies. 
Johnson & Johnson
Johnson & Johnson is the world’s largest independent 
biotech company with a market cap of $343.8 Billion. 
A manufacturer of medical devices, pharmaceutical 
and consumer packaged goods, it is an American 
multinational company that was founded in 1886, with 
its headquarters in New Brunswick, New Jersey. In the 
third quarter of 2017, Johnson & Johnson’s revenue in 
its medical device section was a little more than $19,650 
Million. In Johnson & Johnson’s medical device section, 
the main products they focus on involve general surgery, 
energy science, endocutters, biosurgery, infection 
prevention and wound closure. Medical device sales 
account for 35% of the company’s value. As a company 
that has been around for more than 100 years, Johnson 
& Johnson has been and will continue to be a leader of 
innovation in the medical field.  By 2024, the company’s 
forecasting predicts that its revenue will be around 
$29 Billion. (Johnson & Johnson - Medical Device). 
Johnson & Johnson’s future growth concerns include 
changing healthcare needs for an aging population, 
changing dynamics in the women’s health market, price 
regulation, and developing minimally invasive surgery 
procedures to reduce infections. Johnson & Johnson 
continues to be the world’s leader of innovation among 
biotech companies. 
GE Healthcare
GE Healthcare is a sector of GE Capital, whose parent 
company is General Electric (GE). GE Healthcare offers 
transformational medical technologies and services that 
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are shaping a new age of patient care (GE Healthcare). 
In the third quarter of 2017, GE Healthcare had revenue 
of $4.724 Million, with the medical device segment 
recording a profit of $820 Million. The operation 
profit of the third quarter of 2017 was 17.4%. GE 
Healthcare’s main product categories include accessories 
and supplies, the GE Health Cloud, bone and metabolic 
health, advanced visualization, computed tomography, 
clinical consumables, applied intelligence and anesthesia 
delivery. The GE Health Cloud is “designed to be a 
scalable, secure, connected and interoperable platform, 
delivering the largest application ecosystem for the 
healthcare industry” (GE Health Cloud). It is capable 
of being connected to more than 500,000 GE medical 
imaging machines and more than 1.5 million imaging 
machines worldwide. GE Healthcare is making strides 
in cloud technology to make the healthcare and medical 
world more interconnected.
Porter’s Five Forces
The health of the medical device industry can be gauged 
using Porter’s Five Forces, a common methodology 
that guides analysis of an industry and the competitors 
within it. Porter’s Five Forces are the threat of new 
entrants, rivalry among existing firms, the availability 
of substitutes, bargaining power among buyers, and 
bargaining power among suppliers. Under the first 
force, threat of new entrants, we find that it is extremely 
difficult for new companies to enter this industry due 
to high barriers from strict government regulations. 
The industry is also dominated by a few large and top 
companies who have strong brand images and long-term 
reputations. Barriers to entry include strict regulations 
by the U.S. Food and Drug Administration (FDA), 
such as approvals, requirements, and registrations, as 
well as copyrights and patents. One scholar explains 
the barriers of entry: “There are strict medical device 
regulations for product approval by the FDA, which 
include establishment registration, medical device listing, 
PMA (501) K or premarket approval, investigational 
device exemption (IDE) for clinical studies, quality 
system regulation, labeling requirements and medical 
device reporting (MDR). Couple this with the need for 
copyrights and patents and the barrier rises even higher 
to enter this industry” (UKEssays, 2017). 
In regard to the second force, rivalry amongst 
existing firms, there are eight major competitors in this 
industry. They are Medtronic, Abbott Laboratories, 
Johnson & Johnson, GE Healthcare, Tyco International, 
Boston Scientific, Welch Allyn, and Siemens. The 
medical device industry is rapidly growing and 
constantly changing as a result of new innovations in 
healthcare and technology. Products in this industry 
are typically items found in hospitals, doctors’ offices, 
emergency rooms, and other healthcare facilities. These 
include items such as X-Ray machines, MRI machines, 
beds, monitors, cardiac devices such as pacemakers, 
internal cameras, IV bags, and more. These products also 
have high fixed costs associated with them. The third 
force is substitute products. There are no substitutes 
for these products as they are very specific and cannot 
conceivably be replaced. The threat of new substitutes, as 
a result, is very low. 
The fourth and fifth forces are the bargaining 
power of buyers and suppliers, respectively. First, 
buyers: quite simply, they do not have the ability to 
force down prices. Hospitals and doctors’ offices may 
be able to get deals or discounts when making bulk/
large or frequent purchases. Alternative suppliers exist 
in competitors outside of the United States in Mexico 
and Canada. The importance of these products to the 
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buyers is evident: these medical devices save and improve 
lives. The bargaining power of suppliers is different; they 
can affect the industry with their ability to raise prices. 
They can also contribute to making healthcare more 
expensive. As stated before, the industry is dominated by 
a few companies. Of the eight competitors, the top ones 
are GE Healthcare, Johnson & Johnson, Medtronic, 
Siemens, and Boston Scientific. Their products have 
unique characteristics and are unique themselves. 
Some examples of these products are artificial joints 
and limbs, stents, orthopedic appliances, surgical 
dressings, disposable surgical drapes, hydrotherapy 
appliances, surgical kits, rubber medical and surgical 
gloves, wheelchairs, anesthesia apparatus, orthopedic 
instruments, optical diagnostic apparatus, blood 
transfusion devices, syringes, hypodermic needles, and 
catheters.
Methodology
Data on how these companies and products might 
fare with the end of NAFTA can be organized into 
two tables. The first of these is our External Factors 
Analysis Summary (EFAS) table. The second table is our 
Industry Matrix Analysis. These two tables are crucial 
for planning strategies for the three companies we 
focus on here: GE Healthcare, Johnson & Johnson and 
Medtronic. By utilization of these tables, we can come to 
some useful conclusions.
The External Factors Analysis table acts as a 
means to track the external factors within an industry. 
Prospective changes to NAFTA pose many possible risks 
and opportunities for the healthcare industry. The EFAS 
table helps clarify these opportunities and threats. Our 
research relied on news of the current renegotiations 
of NAFTA through news sites and online newspapers 
(Harwood, 2017). During this research, it was difficult 
to indicate which possible outcomes could occur because 
the negotiations changed pace so quickly and often 
(Heath). The EFAS table lists the opportunities and 
threats that came with each possible change, and how it 
would affect the healthcare and medical device industry 
as a whole. 
Opportunities refer to the advantages that would 
come with specific changes within NAFTA. Here, we 
found five important advantages that would directly 
impact the healthcare and medical device industry. 
Opportunities included lowering the trade deficit 
between the US and Mexico and getting rid of the VAT 
(Harwood, 2017). Threats act as negative effects that 
would hurt the current environment of the healthcare 
and medical device industry. Here, we found five 
threats, including the end of the Maquiladora program 
and the end of resolution panels (Harwood, 2017). 
These two direct elements could affect the medical 
device industry, causing devices sold outside the United 
States to be much more expensive. Given that a large 
amount of manufacturing for medical devices is done 
in Mexico, these two threats would increase the cost of 
manufacturing these products and in turn cause them to 
be more expensive for leading healthcare companies.
The second table is the industry matrix table, which. 
allows us to organize our findings but also to narrow 
down specifics to individual companies within the 
United States, namely Medtronic, Johnson & Johnson, 
and GE Healthcare. The industry matrix lists the 
key success factors needed in order for each of these 
companies to achieve success in the healthcare industry. 
However, each company takes these success factors and 
prioritizes them differently. By using the matrix table 
we are able to show how GE Healthcare, Johnson & 
Johnson, and Medtronic rank each of these success 
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External Factors Weights Rates Comments
Opportunities:
Lower trade deficit between US 
and Mexico 0.05 4 Lowers deficit with Mexico
Get rid of VAT Tax 0.05 3 Gets rid of added tax
Eliminate unfair subsidies 0.1 5 Eliminates extra subsidies for healthcare
Opportunity to impose tariffs 
without permission to congress 0.05 2
Allows tariffs to be added without the 
approval of Congress
Mexico develops internal 
healthcare 0.2 1.5 Mexico to develops their own healthcare
Threats:
End of Maquiladora program 0.05 1
Ends the permit that allows Mexico to 
import duty free
Update rule of origin 0.1 3
Ends the advice and discussion between 
FDA and medical device sponsors
End of resolution panel 0.1 2
Medical devices from Mexico would 
become more expensive
Medical devices from Mexico 
more expensive 0.25 3
Potential loss of jobs/work 0.05 2.5
Total: 1.00
Figure 2: External Factors Analysis
Figure 3: Industry Matrix Table
Medtronic
Johnson & 
Johnson GE Healthcare
Key Success Factors Weight
Weighted 
Score Rating
Weighted 
Score Rating
Weighted 
Score Rating
Innovation 0.2 1 5 0.8 4 1 5
FDA Approval 0.16 0.8 5 0.8 5 0.8 5
Product Development 0.1 0.4 4 0.3 3 0.5 5
Reliable Products 0.15 0.6 4 0.6 4 0.6 4
Top Service Maintenance 0.12 0.36 3 0.6 5 0.48 4
Sales and Marketing 
Effectiveness 0.08 0.4 5 0.24 3 0.32 4
Product Lifecycle 
Management 0.13 0.52 4 0.52 4 0.52 4
Reputation 0.06 0.3 5 0.3 5 0.18 3
Total: 1
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factors. This allows an overview of each company and 
illustrates the main focuses of each leading healthcare 
company. For example, by looking at the first key success 
factor it, is clear that Medtronic and GE Healthcare list 
innovation higher than Johnson & Johnson does (GE 
Healthcare). At the same time, Johnson & Johnson 
ranks service maintenance higher than both Medtronic 
and GE Healthcare (Johnson & Johnson). This shows 
that each company has different focuses and relies on 
different key success factors in order to achieve success.
Findings
Based upon the information presented in the external 
factor analysis summary and industry matrix analysis, we 
can devise strategies for the three companies mentioned 
above, both generally and in relation to possible 
changes in NAFTA. For GE Healthcare, capitalizing 
on innovation is paramount in importance given the 
company’s goals noted in the industry matrix. It ranked 
innovation as one of its top success factors and therefore 
would be focusing on it in the future (GE Healthcare). 
However, due to possible changes in NAFTA, GE’s focus 
on innovation may prove costly. Mexico manufactures 
a large amount of medical devices for these three 
companies and if any of the threats listed in the EFAS 
table occur, innovative technology will not be cheap. In 
light of this, making operations more efficient through 
automation will be useful should the outsourcing of 
manufacturing result in increased costs. Overall, GE 
Healthcare should continue to pursue innovation in 
medical devices, especially in image archiving and cloud 
visualization tools. Outsourcing and operation of devices 
could become more expensive for factories in Mexico, 
and therefore the company should work on ways to 
make the operation process more efficient by using 
automated robotics.
In contrast, Medtronic should continue to 
focus its efforts on charity in order to improve the 
company’s reputation (Medtronic, 2016). By increasing 
its focus on charity events and building a better 
reputation, consumers will be more likely to trust 
and use Medtronic healthcare and services. This type 
of company strategy will bring more popular favor 
toward it and set it apart from its competitors. Like GE 
Healthcare, innovation is also important to Medtronic 
and, because of that, automation is also a key factor 
in Medtronic’s future success. Building the company’s 
reputation will also cultivate more trust from consumers. 
This will in the long run build clientele and give the 
company a competitive edge. Finally, Medtronic should 
also focus on automated manufacturing and increase 
research in its diabetes group, since that is its lowest 
profit group within the company. These key goals will 
allow Medtronic to continue to flourish, even after the 
NAFTA negotiations are complete.
Lastly, Johnson & Johnson should focus on 
its work in the field of minimally invasive surgery (or 
MIS) procedures (Johnson & Johnson). Evidence from 
Johnson & Johnson shows that innovation within the 
medical device field is not as important to the company’s 
focus as it is to GE Healthcare and Medtronic. Instead, 
Johnson & Johnson shows more interest in alternate 
forms of innovation, including those that aim to reduce 
infection rates. Emphasis on these procedures will set 
the company apart from its competitors. Due to possible 
changes from the NAFTA negotiations related to 
manufacturing, Johnson & Johnson’s focus on innovative 
procedures minimizes the need for reconfiguring its 
business model. These require little need for outsourcing 
manufacturing which may become more expensive as 
a result of NAFTA’s renegotiation. MIS procedures are 
also expected to be at a higher demand than they are 
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currently, which will mean a competitive advantage for 
Johnson & Johnson over its leading competitors. 
Conclusion
The goal of this research project has been to analyze 
the medical device industry and its ties to NAFTA. It 
describes the context, business focuses and prospects for 
three top companies in the medical device industry: GE 
Healthcare, Johnson & Johnson, and Medtronic, and 
considers how the scenario of the Trump Administration 
pulling the U.S. out of the trade agreement would 
affect each one. Our study identifies strategies that 
each of the companies could implement if the Trump 
administration were to pull the United States out of 
the North American Free Trade Agreement. While 
Medtronic’s focus on charity is a great way to improve 
its reputation, the company should also increase research 
in its diabetes group since that is its lowest profit group. 
GE Healthcare should continue to increase innovation 
in medical devices, especially in image archiving and 
cloud visualization tools. Outsourcing and operation of 
devices could become more expensive for factories in 
Mexico, so the company should work on ways to make 
the operation process more efficient with automation 
by using robotics. Finally, Johnson & Johnson should 
continue to focus its efforts on innovation in minimally 
invasive surgeries (MIS) as well as other Healthcare 
services. MIS procedures are expected to be at a higher 
demand than they are currently, and this strategy 
would give Johnson & Johnson an advantage over its 
competitors.
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